Invasomes: Vesicles for Enhanced Skin Delivery of Drugs

January 2016 in “ Springer eBooks ”

Nina Dragićević, Daya D. Verma, Alfred Fahr

Studysummary Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Influence of Massage and Occlusion on the Ex Vivo Skin Penetration of Rigid Liposomes and Invasomes

39 citations , November 2013 in “European journal of pharmaceutics and biopharmaceutics”

This study found that massaging the skin significantly increases follicular penetration of liposomes in an ex vivo setting, while occlusion only enhanced penetration for rigid liposomes.

research Transcutol-Containing Vesicles for Topical Delivery of Minoxidil

51 citations , May 2010 in “Journal of Drug Targeting”

This study found that Transcutol-containing vesicles improved the delivery of minoxidil to deeper skin layers in vitro but did not facilitate its permeation through the skin.

research Penetration Enhancer-Containing Vesicles as Carriers for Cutaneous Delivery of Minoxidil

128 citations , July 2009 in “International Journal of Pharmaceutics”

This study found that penetration enhancer-containing vesicles significantly improved minoxidil delivery to the skin compared to traditional liposomes and penetration enhancer-containing ethanolic solutions, with deformability linked to enhanced deposition.

research Ethosomes: New Prospects in Transdermal Delivery

222 citations , January 2003 in “Critical Reviews in Therapeutic Drug Carrier Systems”

This review discusses the capabilities of ethosomes as drug delivery carriers and reports improved outcomes in a clinical study with an ethosomal acyclovir formulation.